Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study
Author(s) -
Andrew MenziesGow,
Claire McBrien,
Bindhu Unni,
Celeste Porsbjerg,
Mona AlAhmad,
Christopher S. Ambrose,
Karin Dahl Assing,
Anna von Bülow,
John Busby,
Borja G. Cosío,
J. Mark FitzGerald,
Esther Garcia Gil,
Susanne Hansen,
Liam G. Heaney,
Mark Hew,
David J. Jackson,
Maria Kallieri,
Stelios Loukides,
Njira Lugogo,
Andriana Ι. Papaioannou,
Désirée LarenasLinnemann,
Wendy C. Moore,
Luis Pérez de Llano,
Linda Rasmussen,
Johannes Martin Schmid,
Salman Siddiqui,
Marianna Alacqua,
Trung N. Tran,
Charlotte Suppli Ulrik,
John W. Upham,
Eileen Wang,
Lakmini Bulathsinhala,
Victoria Carter,
Isha Chaudhry,
Neva Eleangovan,
Ruth Murray,
Chris Price,
David Price
Publication year - 2022
Publication title -
journal of asthma and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.162
H-Index - 30
ISSN - 1178-6965
DOI - 10.2147/jaa.s328653
Subject(s) - medicine , asthma , omalizumab , discontinuation , exacerbation , pediatrics , immunology , immunoglobulin e , antibody
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom